Loricrin (LOR) Peptide
LOR
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
-
- Target See all LOR products
- LOR (Loricrin (LOR))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- GYSGGGCGGG SSGGGGGGGI GGCGGGSGGS VKYSGGGGSS GGGSGCFSSG
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LOR antibody,
Alternative Names: Loricrin control peptide, Loricrin antibody Blocking Peptide, Anti-Loricrin Blocking Peptide, MGC111513 Blocking Peptide, LOR Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LOR (Loricrin (LOR))
- Synonyms
- AI036317 Peptide, S77319 Peptide, RGD1559993 Peptide, LOR Peptide, loricrin Peptide, Loricrin Peptide, LOR Peptide, Lor Peptide, TVAG_146950 Peptide, TVAG_228830 Peptide, TVAG_228920 Peptide, TVAG_238290 Peptide, TVAG_035050 Peptide, TVAG_070680 Peptide, Bm1_52290 Peptide, LOC100281109 Peptide, LOC100281170 Peptide
- Target Type
- Chemical
- Background
- LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.
- Molecular Weight
- 35 kDa
-
You are here:
